Situation: A UK-based CBD skincare manufacturer was subject to an unannounced regulatory inspection. Testing revealed a batch of serum was mislabelled with an inaccurate CBD content and lacked required ingredient documentation from overseas suppliers. The batch was recalled from distributors.
Impact: Costs for recalling stock, disposal, notifying resellers, legal input, and crisis PR support exceeded £45,000. Negative reviews also led to a fall in online sales.
Insurance outcome: The manufacturer’s product recall and legal expenses cover provided prompt funding, expert legal defence, and PR guidance, ensuring business continuity.